Investor event
Johnson & Johnson (JNJ) Q3 2026 Earnings Call
Johnson & Johnson (NYSE: JNJ) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
Latest press releases
- NYSE:JNJ — Johnson & Johnson announces new ICOTYDE® (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through 2-years, affirming its use as a powerful first line systemic therapy · Fri, Oct 2, 2026
- NYSE:JNJ — LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion · Thu, Oct 1, 2026